BioPharma Dive reports the recall adds to safety worries about knockoff weight loss drugs, which stay popular despite FDA warnings and pressure from Lilly and Novo.
Recap by typeshit. Full story at BioPharma Dive.
After his appetite disappeared on tirzepatide, Krasno talks with the Your Best Shot author about food and why scale weight can mask muscle, bone and testosterone loss.
The actress has spoken out with a warning about Ozempic. Only a short link is given, with no details on what she said.
Trials showed low rates, while FAERS and EudraVigilance logged a wider range of events. The Warwick-linked authors call for standardized reporting and close monitoring.
The Democrat & Chronicle lists the affected lot numbers, so anyone using compounded tirzepatide can check their vials.
Osbourne says any medicine can be misused and connects Ozempic to the body image struggles he had when he was younger.
A one-line stock move for the maker of Mounjaro and Zepbound, with no reason given for the gain.
Loading…